|
C5ORF42 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.268800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.723400E-01 |
| Normal-vs-Stage2 |
9.206400E-01 |
| Normal-vs-Stage3 |
4.200800E-01 |
| Normal-vs-Stage4 |
4.976200E-01 |
| Stage1-vs-Stage2 |
7.282800E-01 |
| Stage1-vs-Stage3 |
5.153000E-01 |
| Stage1-vs-Stage4 |
6.179000E-01 |
| Stage2-vs-Stage3 |
4.766800E-01 |
| Stage2-vs-Stage4 |
5.680600E-01 |
| Stage3-vs-Stage4 |
9.446400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.123000E-01 |
| Normal-vs-AfricanAmerican |
8.387400E-01 |
| Normal-vs-Asian |
3.845400E-01 |
| Caucasian-vs-AfricanAmerican |
9.792200E-01 |
| Caucasian-vs-Asian |
5.194400E-01 |
| AfricanAmerican-vs-Asian |
5.086400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.898200E-01 |
| Normal-vs-Female |
3.873200E-01 |
| Male-vs-Female |
1.769980E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.036000E-01 |
| Normal-vs-Extreme_Weight |
7.480000E-01 |
| Normal-vs-Obese |
9.790400E-01 |
| Normal-vs-Extreme_Obese |
2.294200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.378600E-01 |
| Normal_Weight-vs-Obese |
5.605400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.548400E-01 |
| Extreme_Weight-vs-Obese |
6.730200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.303000E-01 |
| Obese-vs-Extreme_Obese |
3.046000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.133000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.034600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.297200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.096400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.630400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.429020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.167600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.156500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.284200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.928400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.412600E-01 |
| Normal-VS-Type2 PRCC |
2.746100E-02 |
| Normal-VS-KIRP CIMP |
5.961600E-01 |
| Normal-VS-Unclassified PRCC |
3.046800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.045600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.422800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.627200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.146400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.935800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.364600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.045700E-02 |
| Normal-vs-N1 |
7.635800E-01 |
| Normal-vs-N2 |
3.306400E-01 |
| N0-vs-N1 |
1.224610E-01 |
| N0-vs-N2 |
8.433800E-01 |
| N1-vs-N2 |
4.311200E-01 |
|
|
